|
|
| Morningstar Overall Rating: |
 |
| Total Assets: |
2.16B |
| Category: |
Health |
| Total Expense Ratio: |
0.86% |
|
| PERFORMANCE & RISK | 31-Jan-10
| YTD Return: |
0.73% |
| 5y Avg Return: |
7.78% |
| Rank in Category (ytd): |
44 |
| % Rank in Category (ytd): |
26.51% |
| Beta (3y): |
0.82 |
| Morningstar Risk Rating: |
Above average |
|
| The investment seeks long-term capital appreciation. The fund normally invests at least 80% of assets in the common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences. While it can invest in companies of any size, the fund invests the majority of assets in large- and mid-capitalization companies. |
|
| Fund Profile |
|
Help
0.29 (1.12%) 
Summary
Add PRHSX to Portfolio 
Download Data
